Tuesday, Mar 19, 2024 | Last Update : 03:01 PM IST

gilead sciences

Dr. Reddy’s releases COVID drug Remdesivir under brand name Redyx

"Dr Reddy's Redyx is available in strength of 100 mg vial," it said

09 Sep 2020 12:21 PM

India's cheapest remdesivir version launched by Zydus Cadila at Rs 2,800 per vial

The drug will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients

13 Aug 2020 11:01 AM

Gilead starts testing inhaled version of remdesivir for COVID-19

Gilead also plans to start additional clinical trials to evaluate remdesivir when used in combination with anti-inflammatory medicines

09 Jul 2020 9:10 AM

Mylan Pharma to launch remdesivir in India at Rs 4,800 per 100 mg vial

The drug will be launched under the brand name Desrem in India and will be available to patients later this month

07 Jul 2020 1:48 PM

Remdesivir gets conditional EU clearance to be used in severe COVID-19 patients

The move comes just days after Gilead allocated nearly all of its supply of remdesivir for the next three months to the US

05 Jul 2020 1:54 PM

ADVERTISEMENT

Gilead Sciences to start trials of inhaled version of remdesivir

The FDA granted remdesivir an emergency use authorisation for the treatment of hospitalised patients with severe Covid-19

23 Jun 2020 3:47 PM

Health ministry okays remdesivir for moderate cases, HCQ for early course of COVID-19

It also okayed off-label application of tocilizumab, a drug that modifies the immune system or its functioning, and convalescent plasma

13 Jun 2020 11:35 PM

AstraZeneca approaches Gilead about potential merger

Gilead, AstraZeneca and several other drugmakers are racing to develop vaccines for COVID-19

07 Jun 2020 4:06 PM

India's drug regulator grants Gilead Sciences marketing authorisation for remdesivir

The approval process for remdesivir was accelerated in view of emergency situation and unmet need for medicines in light of covid19 outbreak

03 Jun 2020 11:57 AM

Gilead ties up with 5 generic drugmakers in India, Pakistan for Covid19 drug supply

The licenses are royalty-free until the World Health Organization declares the end of the public health emergency regarding Covid-19

13 May 2020 8:44 AM

ADVERTISEMENT

Remdesivir shows 'clear-cut' effect in treating coronavirus, says US

The finding represents the first time any medication has been shown to improve outcomes against the COVID-19 illness

30 Apr 2020 9:36 AM

ADVERTISEMENT
ADVERTISEMENT